Fig. 1From: EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patientsMaximum somatic allele frequency (MSAF). a Allele frequency of T790M mutation, EGFR activating mutation, and maximum somatic mutation in 54 patients. AFs were corrected with their copy numbers. b Distribution of the genes with maximum allele frequency among 54 patients. AFs were corrected with their copy numbersBack to article page